Can common-type atrial flutter be a sign of an arrhythmogenic substrate in paroxysmal atrial fibrillation? Clinical and ablative consequences in patients with coexistent paroxysmal atrial fibrillation/atrial flutter.
BACKGROUND
The coexistence of atrial fibrillation (AF) and atrial flutter (AFL) is well recognized. AF precedes the onset of AFL in almost all instances. We evaluated the effect of 2 ablation strategies in patients with paroxysmal AF (PAF) and AFL.


RESULTS
Ninety-eight patients with PAF/AFL were prospectively recruited to undergo pulmonary vein cryoisolation (PVI). Those with at least 1 episode of sustained common-type AFL were assigned to cavotricuspid isthmus cryoablation followed by a 6-week monitoring period and a subsequent PVI (n=36; group I). Patients with PAF only underwent PVI (n=62; group II). The study included 76 men with a mean age of 50+/-10 years. Most patients (76 [78%]) had no structural heart disease. When the 2 groups were compared, residual AF after a blanking period of 3 months after PVI occurred in 24 patients (67%) in group I versus 7 (11%) in group II (P<0.05).


CONCLUSIONS
In patients with PAF and no documented common-type AFL, PVI alone prevented the occurrence of AF in 82%, whereas in patients with AFL/PAF, cavotricuspid isthmus cryoablation and PVI were used successfully to treat sustained common-type AFL but appeared to be insufficient to prevent recurrences of AF. In this population, AFL can be a sign that non-pulmonary vein triggers are the culprit behind AF or that sufficient electrical remodeling has already occurred in both atria, and thus a strategy that includes substrate modification may be required.
Moreira
Wendel
W
Department of Cardiology, Academic Hospital Maastricht, P. Debyelaan 25, PO Box 5800, Maastricht, The Netherlands.
Timmermans
Carl
C
Wellens
Hein J J
HJ
Mizusawa
Yuka
Y
Philippens
Suzanne
S
Perez
David
D
Rodriguez
Luz-Maria
LM
D000328:Adult; D001281:Atrial Fibrillation / Q000150:complications / Q000503:physiopathology* / Q000628:therapy*; D001282:Atrial Flutter / Q000150:complications / Q000503:physiopathology* / Q000628:therapy*; D017115:Catheter Ablation; D003937:Diagnosis, Differential; D004594:Electrophysiology / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011667:Pulmonary Veins / Q000601:surgery; D016896:Treatment Outcome